805 related articles for article (PubMed ID: 33231293)
1. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal conjugate vaccines for preventing otitis media.
Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal conjugate vaccines for preventing otitis media.
Jansen AG; Hak E; Veenhoven RH; Damoiseaux RA; Schilder AG; Sanders EA
Cochrane Database Syst Rev; 2009 Apr; (2):CD001480. PubMed ID: 19370566
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal vaccines for preventing otitis media.
Straetemans M; Sanders EA; Veenhoven RH; Schilder AG; Damoiseaux RA; Zielhuis GA
Cochrane Database Syst Rev; 2004; (1):CD001480. PubMed ID: 14973970
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.
Leach AJ; Wilson N; Arrowsmith B; Beissbarth J; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Chatfield MD; Lehmann D; Binks M; Chang AB; Carapetis J; Krause V; Andrews R; Snelling T; Skull SA; Licciardi PV; Oguoma VM; Morris PS
Lancet Infect Dis; 2022 Sep; 22(9):1374-1387. PubMed ID: 35772449
[TBL] [Abstract][Full Text] [Related]
7. Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions.
Edmondson-Jones M; Dibbern T; Hultberg M; Anell B; Medin E; Feng Y; Talarico C
Hum Vaccin Immunother; 2022 Dec; 18(1):1942712. PubMed ID: 34319865
[TBL] [Abstract][Full Text] [Related]
8. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.
Leach AJ; Wigger C; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2014 Aug; 14():200. PubMed ID: 25109288
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.
Karppinen S; Toivonen L; Schuez-Havupalo L; Teros-Jaakkola T; Waris M; Auranen K; Palmu AA; Peltola V
Vaccine; 2019 May; 37(22):2935-2941. PubMed ID: 31027929
[TBL] [Abstract][Full Text] [Related]
10. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
Vesikari T; Forsten A; Seppä I; Kaijalainen T; Puumalainen T; Soininen A; Traskine M; Lommel P; Schoonbroodt S; Hezareh M; Moreira M; Borys D; Schuerman L
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):237-248. PubMed ID: 27125273
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
Macaj M; Perdochova L; Jakubikova J
Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccines for preventing acute otitis media in infants and children.
Norhayati MN; Ho JJ; Azman MY
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD010089. PubMed ID: 29039160
[TBL] [Abstract][Full Text] [Related]
14. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
[TBL] [Abstract][Full Text] [Related]
15. 10-Valent pneumococcal non-typeable
Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis J; Krause V; Andrews R; Snelling T; Licciardi P; Morris P; Leach AJ
BMJ Open; 2020 May; 10(5):e033511. PubMed ID: 32448790
[TBL] [Abstract][Full Text] [Related]
16. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
Casey JR; Adlowitz DG; Pichichero ME
Pediatr Infect Dis J; 2010 Apr; 29(4):304-9. PubMed ID: 19935445
[TBL] [Abstract][Full Text] [Related]
17. Grommets (ventilation tubes) for recurrent acute otitis media in children.
Venekamp RP; Mick P; Schilder AG; Nunez DA
Cochrane Database Syst Rev; 2018 May; 5(5):CD012017. PubMed ID: 29741289
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county.
Littorin N; Ahl J; Uddén F; Resman F; Riesbeck K
BMC Infect Dis; 2016 Aug; 16(1):407. PubMed ID: 27514843
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.
Tregnaghi MW; Sáez-Llorens X; López P; Abate H; Smith E; Pósleman A; Calvo A; Wong D; Cortes-Barbosa C; Ceballos A; Tregnaghi M; Sierra A; Rodriguez M; Troitiño M; Carabajal C; Falaschi A; Leandro A; Castrejón MM; Lepetic A; Lommel P; Hausdorff WP; Borys D; Ruiz Guiñazú J; Ortega-Barría E; Yarzábal JP; Schuerman L;
PLoS Med; 2014 Jun; 11(6):e1001657. PubMed ID: 24892763
[TBL] [Abstract][Full Text] [Related]
20. Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children.
de Sévaux JLH; Damoiseaux RA; van de Pol AC; Lutje V; Hay AD; Little P; Schilder AG; Venekamp RP
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD011534. PubMed ID: 37594020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
